Last reviewed · How we verify

Prismasol Bk 0/3.5 In Plastic Container (LACTIC ACID)

FDA-approved approved Small molecule Quality 25/100

LACTIC ACID (Prismasol Bk 0/3.5 In Plastic Container) is a marketed topical solution used to alleviate skin itching, with a key composition patent expiring in 2028. Its mechanism of action, which involves altering the skin's pH to reduce itching, provides a distinct therapeutic approach compared to other topical treatments. However, the presence of off-patent competitors such as acetic acid and ascorbic acid, both with multiple generics available, poses a significant market challenge.

At a glance

Generic nameLACTIC ACID
Drug classlactic acid
ModalitySmall molecule
Therapeutic areaDermatology
PhaseFDA-approved
First approval2006

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Patents

PatentExpiryType

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results
FDA Orange BookPatents + exclusivity

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: